AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29190398 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite measure of cigarette perceptions
Number of subjects: 997
Study 29190398 — intervention group
Group type: EXPERIMENTAL
Intervention: Likelihood of trying the cigarettes
Number of subjects: 997
Study 28866454 — intervention group
Group type: EXPERIMENTAL
Intervention: COPD patients
Number of subjects: 40
Study 25624764 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-level thoracic manipulation (STM)
Number of subjects: 48
Study 25624764 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-level thoracic manipulation (MTM)
Number of subjects: 48
Study 25624764 — intervention group
Group type: COMPARATOR
Intervention: Control group (prone lying)
Number of subjects: 48
Study 24068158 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial artery harvest
Number of subjects: 751
Study 24068158 — intervention group
Group type: COMPARATOR
Intervention: Saphenous vein harvest
Number of subjects: 751
Study 21539530 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-body resistive heating (n = 14)
Number of subjects: 28
Study 21539530 — intervention group
Group type: COMPARATOR
Intervention: Forced-air heating (n = 14)
Number of subjects: 28
Study 18045712 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavonoid-rich dark chocolate (Meiji Black Chocolate 45 g, 550 mg cacao polyphenol/day, 200 kcal)
Number of subjects: 39
Study 18045712 — intervention group
Group type: COMPARATOR
Intervention: Non-flavonoid white chocolate (Meiji White Chocolate 35 g, 0 mg cacao polyphenol/day, 140 kcal)
Number of subjects: 39
Study 17667613 — intervention group
Group type: EXPERIMENTAL
Intervention: cyclosporine 0.05% ophthalmic emulsion (RESTASIS) twice daily
Number of subjects: 30
Study 17667613 — intervention group
Group type: EXPERIMENTAL
Intervention: lower‐lid punctal plugs (PARASOL)
Number of subjects: 30
Study 17667613 — intervention group
Group type: EXPERIMENTAL
Intervention: plugs‐cyclosporine combination
Number of subjects: 30
Study 17667613 — intervention group
Group type: COMPARATOR
Intervention: cyclosporine alone
Number of subjects: 30
Study 15581121 — intervention group
Group type: EXPERIMENTAL
Intervention: Imitation using the same side of their bodies as the model (Experiment 1)
Number of subjects: 0
Study 15581121 — intervention group
Group type: EXPERIMENTAL
Intervention: Imitation using the opposite side of their bodies as the model (Experiment 2)
Number of subjects: 0
Study 11197288 — intervention group
Group type: EXPERIMENTAL
Intervention: RAP150 group (pantoprazole 40 mg b.i.d., amoxycillin 1 g b.i.d., rifabutin 150 mg o.d.)
Number of subjects: 135
Study 11197288 — intervention group
Group type: EXPERIMENTAL
Intervention: RAP300 group (pantoprazole 40 mg b.i.d., amoxycillin 1 g b.i.d., rifabutin 300 mg o.d.)
Number of subjects: 135
Study 11197288 — intervention group
Group type: COMPARATOR
Intervention: QT group (pantoprazole 40 mg b.i.d., metronidazole 250 mg t.i.d., bismuth citrate 240 mg b.i.d., tetracycline 500 mg q.i.d.)
Number of subjects: 135
Study 11197288 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifabutin-treated patients
Number of subjects: 135
Study 11197288 — intervention group
Group type: COMPARATOR
Intervention: Quadruple therapy patients
Number of subjects: 135
Study 9673470 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethnic identification assessment
Number of subjects: 545
Study 8019124 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 464
Study 8019124 — intervention group
Group type: COMPARATOR
Intervention: Tobramycin
Number of subjects: 464
Study 2673437 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracosactide (TCS) 2 mg
Number of subjects: 33
Study 2673437 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone (DXM) 20 mg
Number of subjects: 33
Study 339647 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg L-dopa
Number of subjects: 26
Study 339647 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 mg apomorphine
Number of subjects: 26
Study 31094354 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational mobile app plus treatment as usual (TAU)
Number of subjects: 660
Study 31094354 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU) only
Number of subjects: 660
Study 28330700 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping with tension and home exercises
Number of subjects: 40
Study 28330700 — intervention group
Group type: COMPARATOR
Intervention: Kinesio taping without tension and home exercises
Number of subjects: 40
Study 25869422 — intervention group
Group type: EXPERIMENTAL
Intervention: Males with PFP
Number of subjects: 102
Study 25869422 — intervention group
Group type: COMPARATOR
Intervention: Controls (males without PFP)
Number of subjects: 102
Study 23973952 — intervention group
Group type: EXPERIMENTAL
Intervention: Watchman device (Boston Scientific, Natick, MA)
Number of subjects: 80
Study 23973952 — intervention group
Group type: EXPERIMENTAL
Intervention: Amplatzer Cardiac Plug (St Jude Medical, Minneapolis, MN)
Number of subjects: 80
Study 23973952 — intervention group
Group type: EXPERIMENTAL
Intervention: Postprocedural antithrombotic therapy for 6 weeks followed by aspirin
Number of subjects: 80
Study 21455089 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic epidural analgesia (TEA) with bupivacaine 1 mg/mL, epinephrine 2 μg/mL, and fentanyl 2 μg/mL
Number of subjects: 26
Study 21455089 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic epidural analgesia (TEA)
Number of subjects: 26
Study 19245413 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-based model of hospital and in-home follow-up care (individualized exercise strategies, nurse-conducted home visit, and telephone follow-up for 24 weeks).
Number of subjects: 128
Study 19245413 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care).
Number of subjects: 128
Study 17085656 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative short-term radiotherapy
Number of subjects: 1198
Study 17085656 — intervention group
Group type: COMPARATOR
Intervention: No preoperative short-term radiotherapy
Number of subjects: 1198
Study 13678916 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 4809
Study 13678916 — intervention group
Group type: COMPARATOR
Intervention: Abciximab
Number of subjects: 4809
Study 13678916 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirofiban or Abciximab
Number of subjects: 4809
Study 11025866 — intervention group
Group type: EXPERIMENTAL
Intervention: stent-abciximab
Number of subjects: 0
Study 11025866 — intervention group
Group type: COMPARATOR
Intervention: stent-placebo
Number of subjects: 0
Study 11025866 — intervention group
Group type: COMPARATOR
Intervention: balloon-abciximab
Number of subjects: 0
Study 9503814 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoptin-retard (240 mg/day)
Number of subjects: 30
Study 9503814 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 30
Study 8464198 — intervention group
Group type: EXPERIMENTAL
Intervention: Pall PF 30 filter
Number of subjects: 92
Study 8464198 — intervention group
Group type: COMPARATOR
Intervention: No filter (control)
Number of subjects: 92
Study 2931024 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin (intravenous bolus)
Number of subjects: 30
Study 2931024 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin (continuous infusion)
Number of subjects: 30
Study 2931024 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin (discontinued)
Number of subjects: 30
Study 30066201 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative care (PC)
Number of subjects: 923
Study 30066201 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial care (PSC)
Number of subjects: 923
Study 30066201 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy treatment
Number of subjects: 923
Study 30066201 — intervention group
Group type: COMPARATOR
Intervention: Increasing age
Number of subjects: 923
Study 28874502 — intervention group
Group type: EXPERIMENTAL
Intervention: K-wire with external fixation (Ex-Fix)
Number of subjects: 51
Study 28874502 — intervention group
Group type: COMPARATOR
Intervention: K-wire with plaster
Number of subjects: 51
Study 27033674 — intervention group
Group type: EXPERIMENTAL
Intervention: African Dance three times per week for six months
Number of subjects: 80
Study 27033674 — intervention group
Group type: COMPARATOR
Intervention: Educational training on Africana history and culture, and health behaviors three times per week for six months
Number of subjects: 80
Study 25075834 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate administered orally at a daily dose of 2 mg per kilogram of body weight for 3 days, followed by a standard 3-day course of artemisinin-based combination therapy.
Number of subjects: 1241
Study 25075834 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate administered orally at a daily dose of 4 mg per kilogram of body weight for 3 days, followed by a standard 3-day course of artemisinin-based combination therapy.
Number of subjects: 1241
Study 25075834 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-day course of antimalarial therapy in western Cambodia.
Number of subjects: 1241
Study 23297639 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose administration (30 ml for 1 week)
Number of subjects: 58
Study 23297639 — intervention group
Group type: COMPARATOR
Intervention: Control group (surgery without lactulose)
Number of subjects: 58
Study 20534168 — intervention group
Group type: EXPERIMENTAL
Intervention: Vocational rehabilitation plus the Chronic Disease Self‐Management Program (CDSMP) with additional modules on navigating compensation systems and managing return to work.
Number of subjects: 366
Study 20534168 — intervention group
Group type: COMPARATOR
Intervention: Vocational rehabilitation alone (control group)
Number of subjects: 366
Study 18503891 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin administration (Atorvastatin and Pravastatin)
Number of subjects: 108
Study 18503891 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 108
Study 18503891 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 108
Study 18503891 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin administration
Number of subjects: 108
Study 11928030 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 40
Study 11928030 — intervention group
Group type: COMPARATOR
Intervention: Open cholecystectomy (OC)
Number of subjects: 40
Study 9503245 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects with eating disorders (anorexia nervosa and bulimia nervosa)
Number of subjects: 0
Study 9503245 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 0
Study 9503245 — intervention group
Group type: COMPARATOR
Intervention: Restrained eaters
Number of subjects: 0
Study 8277950 — intervention group
Group type: EXPERIMENTAL
Intervention: High sucrose diet (5600 +/- 2100 mg/kg/day)
Number of subjects: 48
Study 8277950 — intervention group
Group type: EXPERIMENTAL
Intervention: Low sucrose diet with aspartame (38 +/- 13 mg/kg/day)
Number of subjects: 48
Study 8277950 — intervention group
Group type: COMPARATOR
Intervention: Low sucrose diet with saccharin (12 +/- 4.5 mg/kg/day)
Number of subjects: 48
Study 2923936 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX) 0.5 mg
Number of subjects: 54
Study 2923936 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX) 1.0 mg
Number of subjects: 54
Study 2923936 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy controls and nondepressed psychiatric patients)
Number of subjects: 54
Study 2923936 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard 1.0‐mg DST
Number of subjects: 54
Study 30654925 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI ≥30 kg/m2
Number of subjects: 399
Study 30654925 — intervention group
Group type: COMPARATOR
Intervention: BMI 25 to 29.9 kg/m2
Number of subjects: 399
Study 30654925 — intervention group
Group type: COMPARATOR
Intervention: BMI <25 kg/m2
Number of subjects: 399
Study 27995373 — intervention group
Group type: EXPERIMENTAL
Intervention: Twelfth subcostal nerve block with lidocaine
Number of subjects: 60
Study 27995373 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular diclofenac
Number of subjects: 60
Study 26176703 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week home-reading programme implemented by caregivers
Number of subjects: 13
Study 26176703 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 13
Study 23867960 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord milking
Number of subjects: 113
Study 23867960 — intervention group
Group type: COMPARATOR
Intervention: Immediate cord clamping
Number of subjects: 113
Study 21677076 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey Protein (WP)
Number of subjects: 90
Study 21677076 — intervention group
Group type: COMPARATOR
Intervention: Soy Protein (SP)
Number of subjects: 90
Study 21677076 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate (CHO)
Number of subjects: 90
Study 19252157 — intervention group
Group type: EXPERIMENTAL
Intervention: Group psychoeducation
Number of subjects: 120
Study 19252157 — intervention group
Group type: COMPARATOR
Intervention: Non-structured group intervention
Number of subjects: 120
Study 16461878 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (12.5 mg/kg per dose every 6 hours)
Number of subjects: 464
Study 16461878 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (5 mg/kg per dose every 8 hours)
Number of subjects: 464
Study 16461878 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternating acetaminophen and ibuprofen (every 4 hours)
Number of subjects: 464
Study 16461878 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 464
Study 14970960 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (titrated up to 125 mg/d)
Number of subjects: 39
Study 14970960 — intervention group
Group type: COMPARATOR
Intervention: Active placebo (benztropine mesylate)
Number of subjects: 39
Study 11773300 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy (four cycles of doxorubicin/cyclophosphamide)
Number of subjects: 0
Study 11773300 — intervention group
Group type: COMPARATOR
Intervention: Postoperative chemotherapy (same regimen)
Number of subjects: 0
Study 11773300 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy
Number of subjects: 0
Study 9009122 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (group I, N = 8)
Number of subjects: 20
Study 9009122 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine plus pirenzepine (group II, N = 12)
Number of subjects: 20
Study 8312728 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient or residential treatment
Number of subjects: 515
Study 8312728 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient treatment
Number of subjects: 515
Study 8312728 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholics Anonymous only
Number of subjects: 515
Study 8312728 — intervention group
Group type: EXPERIMENTAL
Intervention: No treatment
Number of subjects: 515
Study 31907323 — intervention group
Group type: EXPERIMENTAL
Intervention: Pay for Performance (P4P) group paid $150 plus $10 bonus for each of five outcome measures (max $300)
Number of subjects: 35
Study 31907323 — intervention group
Group type: EXPERIMENTAL
Intervention: Pay for Performance (P4P) group
Number of subjects: 35
Study 31907323 — intervention group
Group type: COMPARATOR
Intervention: Control group received $200
Number of subjects: 35
Study 30903685 — intervention group
Group type: EXPERIMENTAL
Intervention: ASTRAL-MP
Number of subjects: 0
Study 30903685 — intervention group
Group type: EXPERIMENTAL
Intervention: ASTRAL-MP (GPU version)
Number of subjects: 0
Study 30903685 — intervention group
Group type: COMPARATOR
Intervention: ASTRAL (single-threaded implementation)
Number of subjects: 0
Study 28318625 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 60
Study 28318625 — intervention group
Group type: COMPARATOR
Intervention: Tacrolimus
Number of subjects: 60
Study 25380193 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 2.5 μg inhaled via Respimat® Soft Mist™ Inhaler
Number of subjects: 92
Study 25380193 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 5 μg inhaled via Respimat® Soft Mist™ Inhaler
Number of subjects: 92
Study 25380193 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 25380193 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium (2.5 μg or 5 μg)
Number of subjects: 92
Study 22930695 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical glyceryl trinitrate (GTN) treatment
Number of subjects: 0
Study 22930695 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study 19700209 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal protection during PCI
Number of subjects: 626
Study 19700209 — intervention group
Group type: COMPARATOR
Intervention: Conventional PCI (without distal protection)
Number of subjects: 626
Study 19457474 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissonance intervention (four-week duration)
Number of subjects: 71
Study 16762763 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticoagulant treatment for acute PE
Number of subjects: 220
Study 16762763 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 220
Study 16762763 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with pulmonary hypertension
Number of subjects: 220
Study 15541822 — intervention group
Group type: EXPERIMENTAL
Intervention: BMS-275291
Number of subjects: 75
Study 15541822 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 11316710 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose vitamin A and E supplementation (25,000 IU retinol palmitate and 230 mg alpha tocopheryl nicotinate)
Number of subjects: 40
Study 11316710 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 9409295 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic oral estradiol combined with progesterone
Number of subjects: 45
Study 9409295 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol combined with progesterone
Number of subjects: 45
Study 9409295 — intervention group
Group type: COMPARATOR
Intervention: No hormonal treatment
Number of subjects: 45
Study 9409295 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 45
Study 8287641 — intervention group
Group type: EXPERIMENTAL
Intervention: E + HC (hyperinsulinaemic clamp followed by hypoglycaemia)
Number of subjects: 10
Study 8287641 — intervention group
Group type: COMPARATOR
Intervention: HC (hypoglycaemic clamp)
Number of subjects: 10
Study 8287641 — intervention group
Group type: EXPERIMENTAL
Intervention: II (insulin infusion only)
Number of subjects: 10
Study 2882967 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental treatment (101 adults and 45 adolescents)
Number of subjects: 278
Study 2882967 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (90 adults and 42 adolescents)
Number of subjects: 278
Study 31287236 — intervention group
Group type: EXPERIMENTAL
Intervention: Coadministration of gemfibrozil 600 mg BID with brigatinib 90 mg
Number of subjects: 60
Study 31287236 — intervention group
Group type: EXPERIMENTAL
Intervention: Coadministration of itraconazole 200 mg BID with brigatinib 90 mg
Number of subjects: 60
Study 31287236 — intervention group
Group type: EXPERIMENTAL
Intervention: Coadministration of rifampin 600 mg QD with brigatinib 180 mg
Number of subjects: 60
Study 30008434 — intervention group
Group type: EXPERIMENTAL
Intervention: Hit n Run video game
Number of subjects: 104
Study 30008434 — intervention group
Group type: COMPARATOR
Intervention: Healthy Eating Step by Step (HESbS) brochure
Number of subjects: 104
Study 27307144 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted outpatient rescreening through collaboration with the WIC program
Number of subjects: 260
Study 27307144 — intervention group
Group type: COMPARATOR
Intervention: Non-WIC infants in the same hospitals (nonintervention)
Number of subjects: 260
Study 27307144 — intervention group
Group type: COMPARATOR
Intervention: Non-WIC infants at nonintervention hospitals
Number of subjects: 260
Study 27307144 — intervention group
Group type: EXPERIMENTAL
Intervention: WIC intervention group
Number of subjects: 260
Study 27307144 — intervention group
Group type: COMPARATOR
Intervention: Non-WIC infants
Number of subjects: 260
Study 24789256 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (BEV) treatment
Number of subjects: 9
Study 22452373 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent atrial fibrillation group
Number of subjects: 308
Study 22452373 — intervention group
Group type: COMPARATOR
Intervention: Control group (no persistent atrial fibrillation)
Number of subjects: 308
Study 22452373 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 308
Study 20402707 — intervention group
Group type: EXPERIMENTAL
Intervention: Flax oil capsules containing 550 mg alpha‐LNA per 1 gram, titrated to 12 capsules per day over 16 weeks
Number of subjects: 51
Study 20402707 — intervention group
Group type: COMPARATOR
Intervention: Olive oil placebo
Number of subjects: 51
Study 20402707 — intervention group
Group type: EXPERIMENTAL
Intervention: Flax oil (alpha‐LNA)
Number of subjects: 51
Study 18562250 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mug/kg fentanyl
Number of subjects: 30
Study 18562250 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 30
Study 16611567 — intervention group
Group type: EXPERIMENTAL
Intervention: Household ceramic water filters
Number of subjects: 60
Study 12558230 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder group (audible and visual reminder at 225 minutes after preoperative antibiotics)
Number of subjects: 273
Study 12558230 — intervention group
Group type: COMPARATOR
Intervention: Control group (no reminder)
Number of subjects: 273
Study 12558230 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder group
Number of subjects: 273
Study 12558230 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 273
Study 12558230 — intervention group
Group type: COMPARATOR
Intervention: Pre-study period
Number of subjects: 273
Study 10824207 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine chest radiography suggesting tuberculosis
Number of subjects: 273